CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Update
by Kim Johansen · The Markets DailyCV Sciences, Inc. (OTCMKTS:CVSI – Get Free Report) was the target of a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 6,400 shares, a decline of 82.5% from the December 15th total of 36,600 shares. Based on an average daily volume of 697,100 shares, the short-interest ratio is currently 0.0 days.
CV Sciences Trading Up 3.6 %
CV Sciences stock traded up $0.00 during midday trading on Monday, hitting $0.03. The stock had a trading volume of 151,081 shares, compared to its average volume of 346,997. CV Sciences has a 52-week low of $0.03 and a 52-week high of $0.10. The company has a market capitalization of $6.36 million, a PE ratio of -3.44 and a beta of 0.66. The firm’s fifty day moving average is $0.04 and its two-hundred day moving average is $0.05.
About CV Sciences
CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.
Read More
- Five stocks we like better than CV Sciences
- What is an Earnings Surprise?
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Delta Can Fly to New Highs in 2025; Here’s Why